Oruka Therapeutics (ORKA) Interest Coverage Ratio (QoQ) (2010 - 2024)
Oruka Therapeutics (ORKA) Interest Coverage Ratio (QoQ) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 59.16% |
| Mar 31, 2024 | 99.19% |
| Dec 31, 2023 | -973.43% |
| Sep 30, 2023 | 87.01% |
| Jun 30, 2023 | 19.44% |
| Sep 30, 2022 | -518.38% |
| Jun 30, 2022 | 93.80% |
| Mar 31, 2022 | -18.99% |
| Dec 31, 2021 | -1,002.22% |
| Sep 30, 2021 | 82.89% |
| Jun 30, 2021 | 92.21% |
| Sep 30, 2020 | -1,798.85% |
| Jun 30, 2020 | 2.24% |
| Mar 31, 2020 | -193.58% |
| Dec 31, 2019 | 78.04% |
| Sep 30, 2019 | -109.49% |
| Jun 30, 2019 | 48.75% |
| Mar 31, 2019 | 89.86% |
| Dec 31, 2018 | 8.12% |
| Sep 30, 2018 | -15.63% |